Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
European Journal of Medicinal Chemistry|December 24, 2021
Synthesis and antiproliferative activity of 6BrCaQ-TPP conjugates for targeting the mitochondrial heat shock protein TRAP1Clelia Mathieu, Quentin Chamayou, Thi Thanh Hyen Luong, et al.
European Journal of Medicinal Chemistry|February 8, 2017
Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitorsIlhem Khelifi, Timothée Naret, Dolor Renko, et al.
European Journal of Medicinal Chemistry|April 1, 2014
Discovery of azaisoerianin derivatives as potential antitumors agentsMohamed Ali Soussi, Olivier Provot, Guillaume Bernadat, et al.
ACS Nano|February 22, 2014
Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacyAndrei Maksimenko, Mouad Alami, Fatima Zouhiri, et al.
European Journal of Medicinal Chemistry|July 31, 2016
Synthesis, biological evaluation and molecular modeling studies of imidazo[1,2-a]pyridines derivatives as protein kinase inhibitorsMarie Lawson, Jordi Rodrigo, Blandine Baratte, et al.
European Journal of Medicinal Chemistry|January 29, 2013
Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogsEvelia Rasolofonjatovo, Olivier Provot, Abdallah Hamze, et al.
European Journal of Medicinal Chemistry|June 25, 2021
Anticancer properties of indole derivatives as IsoCombretastatin A-4 analoguesShannon Pecnard, Abdallah Hamze, Jérome Bignon, et al.
International Journal of Pharmaceutics|January 2, 2016
Formulation and in vitro efficacy of liposomes containing the Hsp90 inhibitor 6BrCaQ in prostate cancer cellsFélix Sauvage, Silvia Franzè, Alexandre Bruneau, et al.
European Journal of Medicinal Chemistry|July 4, 2014
Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitorsDavide Audisio, Délphine Methy-Gonnot, Christine Radanyi, et al.
Communications Biology|March 2, 2021
Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigensRomain Darrigrand, Alison Pierson, Marine Rouillon, et al.
Pageof 10